title: Pseudomyxoma peritonei syndrome.
authors.affiliation: Washington Cancer Institute, Washington, DC, USA.
authors.forename: P H
authors.initials: PH
authors.lastname: Sugarbaker
authors.forename: B M
authors.initials: BM
authors.lastname: Ronnett
authors.forename: A
authors.initials: A
authors.lastname: Archer
authors.forename: A M
authors.initials: AM
authors.lastname: Averbach
authors.forename: R
authors.initials: R
authors.lastname: Bland
authors.forename: D
authors.initials: D
authors.lastname: Chang
authors.forename: R R
authors.initials: RR
authors.lastname: Dalton
authors.forename: S E
authors.initials: SE
authors.lastname: Ettinghausen
authors.forename: P
authors.initials: P
authors.lastname: Jacquet
authors.forename: J
authors.initials: J
authors.lastname: Jelinek
authors.forename: P
authors.initials: P
authors.lastname: Koslowe
authors.forename: R J
authors.initials: RJ
authors.lastname: Kurman
authors.forename: B
authors.initials: B
authors.lastname: Shmookler
authors.forename: A D
authors.initials: AD
authors.lastname: Stephens
authors.forename: M A
authors.initials: MA
authors.lastname: Steves
authors.forename: O A
authors.initials: OA
authors.lastname: Stuart
authors.forename: S
authors.initials: S
authors.lastname: White
authors.forename: C M
authors.initials: CM
authors.lastname: Zahn
authors.forename: F A
authors.initials: FA
authors.lastname: Zoetmulder
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D011553:Pseudomyxoma Peritonei / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate; D014057:Tomography, X-Ray Computed
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil